Global iPSC-Derived Islet Cell Therapy Market Growth (Status and Outlook) 2026-2032
The global iPSC-Derived Islet Cell Therapy market size is predicted to grow from US$ 48.91 million in 2025 to US$ 1145 million in 2032; it is expected to grow at a CAGR of 57.1% from 2026 to 2032.
iPSC-Derived Islet Cell Therapy refers to regenerative medicine products in which somatic cells from autologous patients or donors are reprogrammed into induced pluripotent stem cells (iPSCs), and subsequently differentiated into islet-like cell clusters, ?-cell–enriched populations, or engineered islets composed of multiple endocrine cell types. These products are designed to replace or restore impaired pancreatic islet function in patients with diabetes. They are typically developed as injectable cell suspensions, islet-like cell cluster grafts, or implantable constructs combined with immune isolation devices or bioprinted scaffolds. Key development priorities include glucose-responsive insulin secretion, cellular composition consistency, control of residual undifferentiated cells, immune rejection management, scalable GMP manufacturing, and long-term safety. The overall gross margin is approximately 60%.
Demand for this therapy is primarily driven by the long-term burden of diabetes management, the shortage of donor-derived islets, and the inability of exogenous insulin therapy to restore endogenous glucose regulation. Emerging clinical and preclinical data are gradually expanding islet replacement therapy from a small population of high-risk type 1 diabetes patients toward a broader insulin-dependent diabetes population. As a result, hospitals, research institutions, and large pharmaceutical companies are increasingly interested in standardized, scalable regenerative islet products.
Product development is focused on three main technological pathways: first, autologous iPSC-derived islet cell therapy, which emphasizes immune compatibility and personalized efficacy; second, allogeneic off-the-shelf islet cell banks, which prioritize scalable manufacturing, standardized quality release, and cost efficiency; and third, integrated approaches combining gene-edited hypoimmunogenic cells, immune isolation devices, and bioprinted scaffolds, aiming to reduce or eliminate the need for long-term immunosuppression. Procurement and partnership evaluations typically focus on cell purity, ?-cell proportion, glucose-stimulated insulin secretion, release testing systems, cryostability, implant site compatibility, and long-term clinical durability.
Regionally, the United States and Europe are advancing through collaboration between large pharmaceutical companies, cell therapy developers, and device platform providers. China and Japan are also progressing rapidly, supported by strong iPSC technology foundations, active clinical research ecosystems, and favorable regenerative medicine policies. Key opportunities lie in GMP differentiation processes, master cell banks, immune protection strategies, implantable delivery systems, and companion diagnostic tools. Major risks include tumorigenicity, immune rejection, uncertain long-term efficacy, manufacturing scale-up challenges, pricing and reimbursement constraints, and regulatory approval timelines.
Report Scope
LPI (LP Information)' newest research report, the “iPSC-Derived Islet Cell Therapy Industry Forecast” looks at past sales and reviews total world iPSC-Derived Islet Cell Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected iPSC-Derived Islet Cell Therapy sales for 2026 through 2032. With iPSC-Derived Islet Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world iPSC-Derived Islet Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global iPSC-Derived Islet Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on iPSC-Derived Islet Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global iPSC-Derived Islet Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for iPSC-Derived Islet Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global iPSC-Derived Islet Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of iPSC-Derived Islet Cell Therapy market by product type, application, key players and key regions and countries.
iPSC-Derived Islet Cell Therapy refers to regenerative medicine products in which somatic cells from autologous patients or donors are reprogrammed into induced pluripotent stem cells (iPSCs), and subsequently differentiated into islet-like cell clusters, ?-cell–enriched populations, or engineered islets composed of multiple endocrine cell types. These products are designed to replace or restore impaired pancreatic islet function in patients with diabetes. They are typically developed as injectable cell suspensions, islet-like cell cluster grafts, or implantable constructs combined with immune isolation devices or bioprinted scaffolds. Key development priorities include glucose-responsive insulin secretion, cellular composition consistency, control of residual undifferentiated cells, immune rejection management, scalable GMP manufacturing, and long-term safety. The overall gross margin is approximately 60%.
Demand for this therapy is primarily driven by the long-term burden of diabetes management, the shortage of donor-derived islets, and the inability of exogenous insulin therapy to restore endogenous glucose regulation. Emerging clinical and preclinical data are gradually expanding islet replacement therapy from a small population of high-risk type 1 diabetes patients toward a broader insulin-dependent diabetes population. As a result, hospitals, research institutions, and large pharmaceutical companies are increasingly interested in standardized, scalable regenerative islet products.
Product development is focused on three main technological pathways: first, autologous iPSC-derived islet cell therapy, which emphasizes immune compatibility and personalized efficacy; second, allogeneic off-the-shelf islet cell banks, which prioritize scalable manufacturing, standardized quality release, and cost efficiency; and third, integrated approaches combining gene-edited hypoimmunogenic cells, immune isolation devices, and bioprinted scaffolds, aiming to reduce or eliminate the need for long-term immunosuppression. Procurement and partnership evaluations typically focus on cell purity, ?-cell proportion, glucose-stimulated insulin secretion, release testing systems, cryostability, implant site compatibility, and long-term clinical durability.
Regionally, the United States and Europe are advancing through collaboration between large pharmaceutical companies, cell therapy developers, and device platform providers. China and Japan are also progressing rapidly, supported by strong iPSC technology foundations, active clinical research ecosystems, and favorable regenerative medicine policies. Key opportunities lie in GMP differentiation processes, master cell banks, immune protection strategies, implantable delivery systems, and companion diagnostic tools. Major risks include tumorigenicity, immune rejection, uncertain long-term efficacy, manufacturing scale-up challenges, pricing and reimbursement constraints, and regulatory approval timelines.
Report Scope
LPI (LP Information)' newest research report, the “iPSC-Derived Islet Cell Therapy Industry Forecast” looks at past sales and reviews total world iPSC-Derived Islet Cell Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected iPSC-Derived Islet Cell Therapy sales for 2026 through 2032. With iPSC-Derived Islet Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world iPSC-Derived Islet Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global iPSC-Derived Islet Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on iPSC-Derived Islet Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global iPSC-Derived Islet Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for iPSC-Derived Islet Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global iPSC-Derived Islet Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of iPSC-Derived Islet Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Autologous iPSC-Derived Islet Cell Therapy
- HLA-Matched Allogeneic iPSC-Derived Islet Cell Therapy
- Universal Allogeneic iPSC-Derived Islet Cell Therapy
Segmentation by Cell Composition:
- Beta Cell-Enriched Clusters
- Islet-Like Clusters
- Endocrine Subtype-Complete Islets
- Pancreatic Islet Organoids
Segmentation by Immune Protection Strategy:
- Immunosuppression-Dependent Therapy
- Encapsulation-Protected Therapy
- Hypoimmune Gene-Edited Therapy
- Autologous Immune-Matched Therapy
Segmentation by Transplantation Site:
- Portal Vein or Liver Site
- Subcutaneous Site
- Intramuscular Site
- Omental Site
- Other Implantation Sites
Segmentation by Application:
- Type 1 Diabetes
- Type 2 Diabetes
- Pancreatogenic Diabetes
- Monogenic or Special Diabetes
- Preclinical Research
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Reprogenix Bioscience
- Sana Biotechnology
- Century Therapeutics
- Evotec
- Sernova
- Aspect Biosystems
- Novo Nordisk
- Allele Biotechnology
- SCM Lifescience
- Creative Medical Technology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global iPSC-Derived Islet Cell Therapy Market Size (2021-2032)
2.1.2 iPSC-Derived Islet Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for iPSC-Derived Islet Cell Therapy by Country/Region (2021, 2025 & 2032)
2.2 iPSC-Derived Islet Cell Therapy Segment by Type
2.2.1 Autologous iPSC-Derived Islet Cell Therapy
2.2.2 HLA-Matched Allogeneic iPSC-Derived Islet Cell Therapy
2.2.3 Universal Allogeneic iPSC-Derived Islet Cell Therapy
2.2.4 iPSC-Derived Islet Cell Therapy Market Size by Type
2.2.4.1 iPSC-Derived Islet Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
2.3 iPSC-Derived Islet Cell Therapy Segment by Cell Composition
2.3.1 Beta Cell-Enriched Clusters
2.3.2 Islet-Like Clusters
2.3.3 Endocrine Subtype-Complete Islets
2.3.4 Pancreatic Islet Organoids
2.3.5 iPSC-Derived Islet Cell Therapy Market Size by Cell Composition
2.3.5.1 iPSC-Derived Islet Cell Therapy Market Size CAGR by Cell Composition (2021 VS 2025 VS 2032)
2.3.5.2 Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition (2021-2026)
2.4 iPSC-Derived Islet Cell Therapy Segment by Immune Protection Strategy
2.4.1 Immunosuppression-Dependent Therapy
2.4.2 Encapsulation-Protected Therapy
2.4.3 Hypoimmune Gene-Edited Therapy
2.4.4 Autologous Immune-Matched Therapy
2.4.5 iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy
2.4.5.1 iPSC-Derived Islet Cell Therapy Market Size CAGR by Immune Protection Strategy (2021 VS 2025 VS 2032)
2.4.5.2 Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2026)
2.5 iPSC-Derived Islet Cell Therapy Segment by Transplantation Site
2.5.1 Portal Vein or Liver Site
2.5.2 Subcutaneous Site
2.5.3 Intramuscular Site
2.5.4 Omental Site
2.5.5 Other Implantation Sites
2.5.6 iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site
2.5.6.1 iPSC-Derived Islet Cell Therapy Market Size CAGR by Transplantation Site (2021 VS 2025 VS 2032)
2.5.6.2 Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site (2021-2026)
2.6 iPSC-Derived Islet Cell Therapy Segment by Application
2.6.1 Type 1 Diabetes
2.6.2 Type 2 Diabetes
2.6.3 Pancreatogenic Diabetes
2.6.4 Monogenic or Special Diabetes
2.6.5 Preclinical Research
2.6.6 Other
2.6.7 iPSC-Derived Islet Cell Therapy Market Size by Application
2.6.7.1 iPSC-Derived Islet Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.6.7.2 Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
3 IPSC-DERIVED ISLET CELL THERAPY MARKET SIZE BY PLAYER
3.1 iPSC-Derived Islet Cell Therapy Market Size Market Share by Player
3.1.1 Global iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026)
3.1.2 Global iPSC-Derived Islet Cell Therapy Revenue Market Share by Player (2021-2026)
3.2 Global iPSC-Derived Islet Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IPSC-DERIVED ISLET CELL THERAPY BY REGION
4.1 iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026)
4.2 Global iPSC-Derived Islet Cell Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.4 APAC iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.5 Europe iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026)
5.2 Americas iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
5.3 Americas iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026)
6.2 APAC iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
6.3 APAC iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026)
7.2 Europe iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
7.3 Europe iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa iPSC-Derived Islet Cell Therapy by Region (2021-2026)
8.2 Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IPSC-DERIVED ISLET CELL THERAPY MARKET FORECAST
10.1 Global iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.1.1 Global iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.1.2 Americas iPSC-Derived Islet Cell Therapy Forecast
10.1.3 APAC iPSC-Derived Islet Cell Therapy Forecast
10.1.4 Europe iPSC-Derived Islet Cell Therapy Forecast
10.1.5 Middle East & Africa iPSC-Derived Islet Cell Therapy Forecast
10.2 Americas iPSC-Derived Islet Cell Therapy Forecast by Country (2027-2032)
10.2.1 United States Market iPSC-Derived Islet Cell Therapy Forecast
10.2.2 Canada Market iPSC-Derived Islet Cell Therapy Forecast
10.2.3 Mexico Market iPSC-Derived Islet Cell Therapy Forecast
10.2.4 Brazil Market iPSC-Derived Islet Cell Therapy Forecast
10.3 APAC iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.3.1 China iPSC-Derived Islet Cell Therapy Market Forecast
10.3.2 Japan Market iPSC-Derived Islet Cell Therapy Forecast
10.3.3 Korea Market iPSC-Derived Islet Cell Therapy Forecast
10.3.4 Southeast Asia Market iPSC-Derived Islet Cell Therapy Forecast
10.3.5 India Market iPSC-Derived Islet Cell Therapy Forecast
10.3.6 Australia Market iPSC-Derived Islet Cell Therapy Forecast
10.4 Europe iPSC-Derived Islet Cell Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market iPSC-Derived Islet Cell Therapy Forecast
10.4.2 France Market iPSC-Derived Islet Cell Therapy Forecast
10.4.3 UK Market iPSC-Derived Islet Cell Therapy Forecast
10.4.4 Italy Market iPSC-Derived Islet Cell Therapy Forecast
10.4.5 Russia Market iPSC-Derived Islet Cell Therapy Forecast
10.5 Middle East & Africa iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market iPSC-Derived Islet Cell Therapy Forecast
10.5.2 South Africa Market iPSC-Derived Islet Cell Therapy Forecast
10.5.3 Israel Market iPSC-Derived Islet Cell Therapy Forecast
10.5.4 Turkey Market iPSC-Derived Islet Cell Therapy Forecast
10.6 Global iPSC-Derived Islet Cell Therapy Forecast by Type (2027-2032)
10.7 Global iPSC-Derived Islet Cell Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market iPSC-Derived Islet Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Reprogenix Bioscience
11.1.1 Reprogenix Bioscience Company Information
11.1.2 Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Product Offered
11.1.3 Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Reprogenix Bioscience Main Business Overview
11.1.5 Reprogenix Bioscience Latest Developments
11.2 Sana Biotechnology
11.2.1 Sana Biotechnology Company Information
11.2.2 Sana Biotechnology iPSC-Derived Islet Cell Therapy Product Offered
11.2.3 Sana Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Sana Biotechnology Main Business Overview
11.2.5 Sana Biotechnology Latest Developments
11.3 Century Therapeutics
11.3.1 Century Therapeutics Company Information
11.3.2 Century Therapeutics iPSC-Derived Islet Cell Therapy Product Offered
11.3.3 Century Therapeutics iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Century Therapeutics Main Business Overview
11.3.5 Century Therapeutics Latest Developments
11.4 Evotec
11.4.1 Evotec Company Information
11.4.2 Evotec iPSC-Derived Islet Cell Therapy Product Offered
11.4.3 Evotec iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Evotec Main Business Overview
11.4.5 Evotec Latest Developments
11.5 Sernova
11.5.1 Sernova Company Information
11.5.2 Sernova iPSC-Derived Islet Cell Therapy Product Offered
11.5.3 Sernova iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sernova Main Business Overview
11.5.5 Sernova Latest Developments
11.6 Aspect Biosystems
11.6.1 Aspect Biosystems Company Information
11.6.2 Aspect Biosystems iPSC-Derived Islet Cell Therapy Product Offered
11.6.3 Aspect Biosystems iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Aspect Biosystems Main Business Overview
11.6.5 Aspect Biosystems Latest Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk iPSC-Derived Islet Cell Therapy Product Offered
11.7.3 Novo Nordisk iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novo Nordisk Main Business Overview
11.7.5 Novo Nordisk Latest Developments
11.8 Allele Biotechnology
11.8.1 Allele Biotechnology Company Information
11.8.2 Allele Biotechnology iPSC-Derived Islet Cell Therapy Product Offered
11.8.3 Allele Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Allele Biotechnology Main Business Overview
11.8.5 Allele Biotechnology Latest Developments
11.9 SCM Lifescience
11.9.1 SCM Lifescience Company Information
11.9.2 SCM Lifescience iPSC-Derived Islet Cell Therapy Product Offered
11.9.3 SCM Lifescience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 SCM Lifescience Main Business Overview
11.9.5 SCM Lifescience Latest Developments
11.10 Creative Medical Technology
11.10.1 Creative Medical Technology Company Information
11.10.2 Creative Medical Technology iPSC-Derived Islet Cell Therapy Product Offered
11.10.3 Creative Medical Technology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Creative Medical Technology Main Business Overview
11.10.5 Creative Medical Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global iPSC-Derived Islet Cell Therapy Market Size (2021-2032)
2.1.2 iPSC-Derived Islet Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for iPSC-Derived Islet Cell Therapy by Country/Region (2021, 2025 & 2032)
2.2 iPSC-Derived Islet Cell Therapy Segment by Type
2.2.1 Autologous iPSC-Derived Islet Cell Therapy
2.2.2 HLA-Matched Allogeneic iPSC-Derived Islet Cell Therapy
2.2.3 Universal Allogeneic iPSC-Derived Islet Cell Therapy
2.2.4 iPSC-Derived Islet Cell Therapy Market Size by Type
2.2.4.1 iPSC-Derived Islet Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
2.3 iPSC-Derived Islet Cell Therapy Segment by Cell Composition
2.3.1 Beta Cell-Enriched Clusters
2.3.2 Islet-Like Clusters
2.3.3 Endocrine Subtype-Complete Islets
2.3.4 Pancreatic Islet Organoids
2.3.5 iPSC-Derived Islet Cell Therapy Market Size by Cell Composition
2.3.5.1 iPSC-Derived Islet Cell Therapy Market Size CAGR by Cell Composition (2021 VS 2025 VS 2032)
2.3.5.2 Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition (2021-2026)
2.4 iPSC-Derived Islet Cell Therapy Segment by Immune Protection Strategy
2.4.1 Immunosuppression-Dependent Therapy
2.4.2 Encapsulation-Protected Therapy
2.4.3 Hypoimmune Gene-Edited Therapy
2.4.4 Autologous Immune-Matched Therapy
2.4.5 iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy
2.4.5.1 iPSC-Derived Islet Cell Therapy Market Size CAGR by Immune Protection Strategy (2021 VS 2025 VS 2032)
2.4.5.2 Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2026)
2.5 iPSC-Derived Islet Cell Therapy Segment by Transplantation Site
2.5.1 Portal Vein or Liver Site
2.5.2 Subcutaneous Site
2.5.3 Intramuscular Site
2.5.4 Omental Site
2.5.5 Other Implantation Sites
2.5.6 iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site
2.5.6.1 iPSC-Derived Islet Cell Therapy Market Size CAGR by Transplantation Site (2021 VS 2025 VS 2032)
2.5.6.2 Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site (2021-2026)
2.6 iPSC-Derived Islet Cell Therapy Segment by Application
2.6.1 Type 1 Diabetes
2.6.2 Type 2 Diabetes
2.6.3 Pancreatogenic Diabetes
2.6.4 Monogenic or Special Diabetes
2.6.5 Preclinical Research
2.6.6 Other
2.6.7 iPSC-Derived Islet Cell Therapy Market Size by Application
2.6.7.1 iPSC-Derived Islet Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.6.7.2 Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
3 IPSC-DERIVED ISLET CELL THERAPY MARKET SIZE BY PLAYER
3.1 iPSC-Derived Islet Cell Therapy Market Size Market Share by Player
3.1.1 Global iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026)
3.1.2 Global iPSC-Derived Islet Cell Therapy Revenue Market Share by Player (2021-2026)
3.2 Global iPSC-Derived Islet Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IPSC-DERIVED ISLET CELL THERAPY BY REGION
4.1 iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026)
4.2 Global iPSC-Derived Islet Cell Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.4 APAC iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.5 Europe iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026)
5.2 Americas iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
5.3 Americas iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026)
6.2 APAC iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
6.3 APAC iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026)
7.2 Europe iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
7.3 Europe iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa iPSC-Derived Islet Cell Therapy by Region (2021-2026)
8.2 Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IPSC-DERIVED ISLET CELL THERAPY MARKET FORECAST
10.1 Global iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.1.1 Global iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.1.2 Americas iPSC-Derived Islet Cell Therapy Forecast
10.1.3 APAC iPSC-Derived Islet Cell Therapy Forecast
10.1.4 Europe iPSC-Derived Islet Cell Therapy Forecast
10.1.5 Middle East & Africa iPSC-Derived Islet Cell Therapy Forecast
10.2 Americas iPSC-Derived Islet Cell Therapy Forecast by Country (2027-2032)
10.2.1 United States Market iPSC-Derived Islet Cell Therapy Forecast
10.2.2 Canada Market iPSC-Derived Islet Cell Therapy Forecast
10.2.3 Mexico Market iPSC-Derived Islet Cell Therapy Forecast
10.2.4 Brazil Market iPSC-Derived Islet Cell Therapy Forecast
10.3 APAC iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.3.1 China iPSC-Derived Islet Cell Therapy Market Forecast
10.3.2 Japan Market iPSC-Derived Islet Cell Therapy Forecast
10.3.3 Korea Market iPSC-Derived Islet Cell Therapy Forecast
10.3.4 Southeast Asia Market iPSC-Derived Islet Cell Therapy Forecast
10.3.5 India Market iPSC-Derived Islet Cell Therapy Forecast
10.3.6 Australia Market iPSC-Derived Islet Cell Therapy Forecast
10.4 Europe iPSC-Derived Islet Cell Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market iPSC-Derived Islet Cell Therapy Forecast
10.4.2 France Market iPSC-Derived Islet Cell Therapy Forecast
10.4.3 UK Market iPSC-Derived Islet Cell Therapy Forecast
10.4.4 Italy Market iPSC-Derived Islet Cell Therapy Forecast
10.4.5 Russia Market iPSC-Derived Islet Cell Therapy Forecast
10.5 Middle East & Africa iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market iPSC-Derived Islet Cell Therapy Forecast
10.5.2 South Africa Market iPSC-Derived Islet Cell Therapy Forecast
10.5.3 Israel Market iPSC-Derived Islet Cell Therapy Forecast
10.5.4 Turkey Market iPSC-Derived Islet Cell Therapy Forecast
10.6 Global iPSC-Derived Islet Cell Therapy Forecast by Type (2027-2032)
10.7 Global iPSC-Derived Islet Cell Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market iPSC-Derived Islet Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Reprogenix Bioscience
11.1.1 Reprogenix Bioscience Company Information
11.1.2 Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Product Offered
11.1.3 Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Reprogenix Bioscience Main Business Overview
11.1.5 Reprogenix Bioscience Latest Developments
11.2 Sana Biotechnology
11.2.1 Sana Biotechnology Company Information
11.2.2 Sana Biotechnology iPSC-Derived Islet Cell Therapy Product Offered
11.2.3 Sana Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Sana Biotechnology Main Business Overview
11.2.5 Sana Biotechnology Latest Developments
11.3 Century Therapeutics
11.3.1 Century Therapeutics Company Information
11.3.2 Century Therapeutics iPSC-Derived Islet Cell Therapy Product Offered
11.3.3 Century Therapeutics iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Century Therapeutics Main Business Overview
11.3.5 Century Therapeutics Latest Developments
11.4 Evotec
11.4.1 Evotec Company Information
11.4.2 Evotec iPSC-Derived Islet Cell Therapy Product Offered
11.4.3 Evotec iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Evotec Main Business Overview
11.4.5 Evotec Latest Developments
11.5 Sernova
11.5.1 Sernova Company Information
11.5.2 Sernova iPSC-Derived Islet Cell Therapy Product Offered
11.5.3 Sernova iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sernova Main Business Overview
11.5.5 Sernova Latest Developments
11.6 Aspect Biosystems
11.6.1 Aspect Biosystems Company Information
11.6.2 Aspect Biosystems iPSC-Derived Islet Cell Therapy Product Offered
11.6.3 Aspect Biosystems iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Aspect Biosystems Main Business Overview
11.6.5 Aspect Biosystems Latest Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk iPSC-Derived Islet Cell Therapy Product Offered
11.7.3 Novo Nordisk iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novo Nordisk Main Business Overview
11.7.5 Novo Nordisk Latest Developments
11.8 Allele Biotechnology
11.8.1 Allele Biotechnology Company Information
11.8.2 Allele Biotechnology iPSC-Derived Islet Cell Therapy Product Offered
11.8.3 Allele Biotechnology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Allele Biotechnology Main Business Overview
11.8.5 Allele Biotechnology Latest Developments
11.9 SCM Lifescience
11.9.1 SCM Lifescience Company Information
11.9.2 SCM Lifescience iPSC-Derived Islet Cell Therapy Product Offered
11.9.3 SCM Lifescience iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 SCM Lifescience Main Business Overview
11.9.5 SCM Lifescience Latest Developments
11.10 Creative Medical Technology
11.10.1 Creative Medical Technology Company Information
11.10.2 Creative Medical Technology iPSC-Derived Islet Cell Therapy Product Offered
11.10.3 Creative Medical Technology iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Creative Medical Technology Main Business Overview
11.10.5 Creative Medical Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. iPSC-Derived Islet Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. iPSC-Derived Islet Cell Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Autologous iPSC-Derived Islet Cell Therapy
Table 4. Major Players of HLA-Matched Allogeneic iPSC-Derived Islet Cell Therapy
Table 5. Major Players of Universal Allogeneic iPSC-Derived Islet Cell Therapy
Table 6. iPSC-Derived Islet Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 8. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Beta Cell-Enriched Clusters
Table 10. Major Players of Islet-Like Clusters
Table 11. Major Players of Endocrine Subtype-Complete Islets
Table 12. Major Players of Pancreatic Islet Organoids
Table 13. iPSC-Derived Islet Cell Therapy Market Size CAGR by Cell Composition (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global iPSC-Derived Islet Cell Therapy Market Size by Cell Composition (2021-2026) & ($ millions)
Table 15. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition (2021-2026)
Table 16. Major Players of Immunosuppression-Dependent Therapy
Table 17. Major Players of Encapsulation-Protected Therapy
Table 18. Major Players of Hypoimmune Gene-Edited Therapy
Table 19. Major Players of Autologous Immune-Matched Therapy
Table 20. iPSC-Derived Islet Cell Therapy Market Size CAGR by Immune Protection Strategy (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2021-2026) & ($ millions)
Table 22. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2026)
Table 23. Major Players of Portal Vein or Liver Site
Table 24. Major Players of Subcutaneous Site
Table 25. Major Players of Intramuscular Site
Table 26. Major Players of Omental Site
Table 27. Major Players of Other Implantation Sites
Table 28. iPSC-Derived Islet Cell Therapy Market Size CAGR by Transplantation Site (2021 VS 2025 VS 2032) & ($ millions)
Table 29. Global iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site (2021-2026) & ($ millions)
Table 30. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site (2021-2026)
Table 31. iPSC-Derived Islet Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 32. Global iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 33. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Table 34. Global iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026) & ($ millions)
Table 35. Global iPSC-Derived Islet Cell Therapy Revenue Market Share by Player (2021-2026)
Table 36. iPSC-Derived Islet Cell Therapy Key Players Head office and Products Offered
Table 37. iPSC-Derived Islet Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Mergers & Acquisitions, Expansion
Table 40. Global iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 41. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Table 42. Global iPSC-Derived Islet Cell Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 43. Global iPSC-Derived Islet Cell Therapy Revenue Market Share by Country/Region (2021-2026)
Table 44. Americas iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 45. Americas iPSC-Derived Islet Cell Therapy Market Size Market Share by Country (2021-2026)
Table 46. Americas iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 47. Americas iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Table 48. Americas iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 49. Americas iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Table 50. APAC iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 51. APAC iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Table 52. APAC iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 53. APAC iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 54. Europe iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 55. Europe iPSC-Derived Islet Cell Therapy Market Size Market Share by Country (2021-2026)
Table 56. Europe iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 57. Europe iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 58. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 59. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 60. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 61. Key Market Drivers & Growth Opportunities of iPSC-Derived Islet Cell Therapy
Table 62. Key Market Challenges & Risks of iPSC-Derived Islet Cell Therapy
Table 63. Key Industry Trends of iPSC-Derived Islet Cell Therapy
Table 64. Global iPSC-Derived Islet Cell Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 65. Global iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 66. Global iPSC-Derived Islet Cell Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 67. Global iPSC-Derived Islet Cell Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 68. Reprogenix Bioscience Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 69. Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Product Offered
Table 70. Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Reprogenix Bioscience Main Business
Table 72. Reprogenix Bioscience Latest Developments
Table 73. Sana Biotechnology Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 74. Sana Biotechnology iPSC-Derived Islet Cell Therapy Product Offered
Table 75. Sana Biotechnology iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Sana Biotechnology Main Business
Table 77. Sana Biotechnology Latest Developments
Table 78. Century Therapeutics Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 79. Century Therapeutics iPSC-Derived Islet Cell Therapy Product Offered
Table 80. Century Therapeutics iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Century Therapeutics Main Business
Table 82. Century Therapeutics Latest Developments
Table 83. Evotec Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 84. Evotec iPSC-Derived Islet Cell Therapy Product Offered
Table 85. Evotec iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Evotec Main Business
Table 87. Evotec Latest Developments
Table 88. Sernova Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 89. Sernova iPSC-Derived Islet Cell Therapy Product Offered
Table 90. Sernova iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Sernova Main Business
Table 92. Sernova Latest Developments
Table 93. Aspect Biosystems Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 94. Aspect Biosystems iPSC-Derived Islet Cell Therapy Product Offered
Table 95. Aspect Biosystems iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Aspect Biosystems Main Business
Table 97. Aspect Biosystems Latest Developments
Table 98. Novo Nordisk Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 99. Novo Nordisk iPSC-Derived Islet Cell Therapy Product Offered
Table 100. Novo Nordisk iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Novo Nordisk Main Business
Table 102. Novo Nordisk Latest Developments
Table 103. Allele Biotechnology Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 104. Allele Biotechnology iPSC-Derived Islet Cell Therapy Product Offered
Table 105. Allele Biotechnology iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Allele Biotechnology Main Business
Table 107. Allele Biotechnology Latest Developments
Table 108. SCM Lifescience Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 109. SCM Lifescience iPSC-Derived Islet Cell Therapy Product Offered
Table 110. SCM Lifescience iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. SCM Lifescience Main Business
Table 112. SCM Lifescience Latest Developments
Table 113. Creative Medical Technology Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 114. Creative Medical Technology iPSC-Derived Islet Cell Therapy Product Offered
Table 115. Creative Medical Technology iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Creative Medical Technology Main Business
Table 117. Creative Medical Technology Latest Developments
Table 1. iPSC-Derived Islet Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. iPSC-Derived Islet Cell Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Autologous iPSC-Derived Islet Cell Therapy
Table 4. Major Players of HLA-Matched Allogeneic iPSC-Derived Islet Cell Therapy
Table 5. Major Players of Universal Allogeneic iPSC-Derived Islet Cell Therapy
Table 6. iPSC-Derived Islet Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 8. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Beta Cell-Enriched Clusters
Table 10. Major Players of Islet-Like Clusters
Table 11. Major Players of Endocrine Subtype-Complete Islets
Table 12. Major Players of Pancreatic Islet Organoids
Table 13. iPSC-Derived Islet Cell Therapy Market Size CAGR by Cell Composition (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global iPSC-Derived Islet Cell Therapy Market Size by Cell Composition (2021-2026) & ($ millions)
Table 15. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition (2021-2026)
Table 16. Major Players of Immunosuppression-Dependent Therapy
Table 17. Major Players of Encapsulation-Protected Therapy
Table 18. Major Players of Hypoimmune Gene-Edited Therapy
Table 19. Major Players of Autologous Immune-Matched Therapy
Table 20. iPSC-Derived Islet Cell Therapy Market Size CAGR by Immune Protection Strategy (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2021-2026) & ($ millions)
Table 22. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2026)
Table 23. Major Players of Portal Vein or Liver Site
Table 24. Major Players of Subcutaneous Site
Table 25. Major Players of Intramuscular Site
Table 26. Major Players of Omental Site
Table 27. Major Players of Other Implantation Sites
Table 28. iPSC-Derived Islet Cell Therapy Market Size CAGR by Transplantation Site (2021 VS 2025 VS 2032) & ($ millions)
Table 29. Global iPSC-Derived Islet Cell Therapy Market Size by Transplantation Site (2021-2026) & ($ millions)
Table 30. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site (2021-2026)
Table 31. iPSC-Derived Islet Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 32. Global iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 33. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Table 34. Global iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026) & ($ millions)
Table 35. Global iPSC-Derived Islet Cell Therapy Revenue Market Share by Player (2021-2026)
Table 36. iPSC-Derived Islet Cell Therapy Key Players Head office and Products Offered
Table 37. iPSC-Derived Islet Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Mergers & Acquisitions, Expansion
Table 40. Global iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 41. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Table 42. Global iPSC-Derived Islet Cell Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 43. Global iPSC-Derived Islet Cell Therapy Revenue Market Share by Country/Region (2021-2026)
Table 44. Americas iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 45. Americas iPSC-Derived Islet Cell Therapy Market Size Market Share by Country (2021-2026)
Table 46. Americas iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 47. Americas iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Table 48. Americas iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 49. Americas iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Table 50. APAC iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 51. APAC iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Table 52. APAC iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 53. APAC iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 54. Europe iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 55. Europe iPSC-Derived Islet Cell Therapy Market Size Market Share by Country (2021-2026)
Table 56. Europe iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 57. Europe iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 58. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 59. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 60. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 61. Key Market Drivers & Growth Opportunities of iPSC-Derived Islet Cell Therapy
Table 62. Key Market Challenges & Risks of iPSC-Derived Islet Cell Therapy
Table 63. Key Industry Trends of iPSC-Derived Islet Cell Therapy
Table 64. Global iPSC-Derived Islet Cell Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 65. Global iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 66. Global iPSC-Derived Islet Cell Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 67. Global iPSC-Derived Islet Cell Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 68. Reprogenix Bioscience Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 69. Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Product Offered
Table 70. Reprogenix Bioscience iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Reprogenix Bioscience Main Business
Table 72. Reprogenix Bioscience Latest Developments
Table 73. Sana Biotechnology Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 74. Sana Biotechnology iPSC-Derived Islet Cell Therapy Product Offered
Table 75. Sana Biotechnology iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Sana Biotechnology Main Business
Table 77. Sana Biotechnology Latest Developments
Table 78. Century Therapeutics Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 79. Century Therapeutics iPSC-Derived Islet Cell Therapy Product Offered
Table 80. Century Therapeutics iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Century Therapeutics Main Business
Table 82. Century Therapeutics Latest Developments
Table 83. Evotec Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 84. Evotec iPSC-Derived Islet Cell Therapy Product Offered
Table 85. Evotec iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Evotec Main Business
Table 87. Evotec Latest Developments
Table 88. Sernova Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 89. Sernova iPSC-Derived Islet Cell Therapy Product Offered
Table 90. Sernova iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Sernova Main Business
Table 92. Sernova Latest Developments
Table 93. Aspect Biosystems Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 94. Aspect Biosystems iPSC-Derived Islet Cell Therapy Product Offered
Table 95. Aspect Biosystems iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Aspect Biosystems Main Business
Table 97. Aspect Biosystems Latest Developments
Table 98. Novo Nordisk Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 99. Novo Nordisk iPSC-Derived Islet Cell Therapy Product Offered
Table 100. Novo Nordisk iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Novo Nordisk Main Business
Table 102. Novo Nordisk Latest Developments
Table 103. Allele Biotechnology Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 104. Allele Biotechnology iPSC-Derived Islet Cell Therapy Product Offered
Table 105. Allele Biotechnology iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Allele Biotechnology Main Business
Table 107. Allele Biotechnology Latest Developments
Table 108. SCM Lifescience Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 109. SCM Lifescience iPSC-Derived Islet Cell Therapy Product Offered
Table 110. SCM Lifescience iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. SCM Lifescience Main Business
Table 112. SCM Lifescience Latest Developments
Table 113. Creative Medical Technology Details, Company Type, iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 114. Creative Medical Technology iPSC-Derived Islet Cell Therapy Product Offered
Table 115. Creative Medical Technology iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Creative Medical Technology Main Business
Table 117. Creative Medical Technology Latest Developments
LIST OF FIGURES
Figure 1. iPSC-Derived Islet Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global iPSC-Derived Islet Cell Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. iPSC-Derived Islet Cell Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. iPSC-Derived Islet Cell Therapy Sales Market Share by Country/Region (2025)
Figure 8. iPSC-Derived Islet Cell Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Type in 2025
Figure 10. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition in 2025
Figure 11. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy in 2025
Figure 12. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site in 2025
Figure 13. iPSC-Derived Islet Cell Therapy in Type 1 Diabetes
Figure 14. Global iPSC-Derived Islet Cell Therapy Market: Type 1 Diabetes (2021-2026) & ($ millions)
Figure 15. iPSC-Derived Islet Cell Therapy in Type 2 Diabetes
Figure 16. Global iPSC-Derived Islet Cell Therapy Market: Type 2 Diabetes (2021-2026) & ($ millions)
Figure 17. iPSC-Derived Islet Cell Therapy in Pancreatogenic Diabetes
Figure 18. Global iPSC-Derived Islet Cell Therapy Market: Pancreatogenic Diabetes (2021-2026) & ($ millions)
Figure 19. iPSC-Derived Islet Cell Therapy in Monogenic or Special Diabetes
Figure 20. Global iPSC-Derived Islet Cell Therapy Market: Monogenic or Special Diabetes (2021-2026) & ($ millions)
Figure 21. iPSC-Derived Islet Cell Therapy in Preclinical Research
Figure 22. Global iPSC-Derived Islet Cell Therapy Market: Preclinical Research (2021-2026) & ($ millions)
Figure 23. iPSC-Derived Islet Cell Therapy in Other
Figure 24. Global iPSC-Derived Islet Cell Therapy Market: Other (2021-2026) & ($ millions)
Figure 25. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Application in 2025
Figure 26. Global iPSC-Derived Islet Cell Therapy Revenue Market Share by Player in 2025
Figure 27. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 28. Americas iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 29. APAC iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 30. Europe iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 31. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 32. Americas iPSC-Derived Islet Cell Therapy Value Market Share by Country in 2025
Figure 33. United States iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Canada iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. Mexico iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Brazil iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. APAC iPSC-Derived Islet Cell Therapy Market Size Market Share by Region in 2025
Figure 38. APAC iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 39. APAC iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 40. China iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Japan iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. South Korea iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Southeast Asia iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. India iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Australia iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 46. Europe iPSC-Derived Islet Cell Therapy Market Size Market Share by Country in 2025
Figure 47. Europe iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 48. Europe iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 49. Germany iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. France iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. UK iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. Italy iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Russia iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 54. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 55. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 56. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 57. Egypt iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 58. South Africa iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 59. Israel iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 60. Turkey iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 61. GCC Countries iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 62. Americas iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 63. APAC iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 64. Europe iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 65. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 66. United States iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 67. Canada iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 68. Mexico iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 69. Brazil iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 70. China iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 71. Japan iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 72. Korea iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 73. Southeast Asia iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 74. India iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 75. Australia iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 76. Germany iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 77. France iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 78. UK iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 79. Italy iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 80. Russia iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 81. Egypt iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 82. South Africa iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 83. Israel iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 84. Turkey iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 85. Global iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 86. Global iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 87. GCC Countries iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 1. iPSC-Derived Islet Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global iPSC-Derived Islet Cell Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. iPSC-Derived Islet Cell Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. iPSC-Derived Islet Cell Therapy Sales Market Share by Country/Region (2025)
Figure 8. iPSC-Derived Islet Cell Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Type in 2025
Figure 10. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Composition in 2025
Figure 11. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy in 2025
Figure 12. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Transplantation Site in 2025
Figure 13. iPSC-Derived Islet Cell Therapy in Type 1 Diabetes
Figure 14. Global iPSC-Derived Islet Cell Therapy Market: Type 1 Diabetes (2021-2026) & ($ millions)
Figure 15. iPSC-Derived Islet Cell Therapy in Type 2 Diabetes
Figure 16. Global iPSC-Derived Islet Cell Therapy Market: Type 2 Diabetes (2021-2026) & ($ millions)
Figure 17. iPSC-Derived Islet Cell Therapy in Pancreatogenic Diabetes
Figure 18. Global iPSC-Derived Islet Cell Therapy Market: Pancreatogenic Diabetes (2021-2026) & ($ millions)
Figure 19. iPSC-Derived Islet Cell Therapy in Monogenic or Special Diabetes
Figure 20. Global iPSC-Derived Islet Cell Therapy Market: Monogenic or Special Diabetes (2021-2026) & ($ millions)
Figure 21. iPSC-Derived Islet Cell Therapy in Preclinical Research
Figure 22. Global iPSC-Derived Islet Cell Therapy Market: Preclinical Research (2021-2026) & ($ millions)
Figure 23. iPSC-Derived Islet Cell Therapy in Other
Figure 24. Global iPSC-Derived Islet Cell Therapy Market: Other (2021-2026) & ($ millions)
Figure 25. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Application in 2025
Figure 26. Global iPSC-Derived Islet Cell Therapy Revenue Market Share by Player in 2025
Figure 27. Global iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 28. Americas iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 29. APAC iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 30. Europe iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 31. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 32. Americas iPSC-Derived Islet Cell Therapy Value Market Share by Country in 2025
Figure 33. United States iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Canada iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. Mexico iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Brazil iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. APAC iPSC-Derived Islet Cell Therapy Market Size Market Share by Region in 2025
Figure 38. APAC iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 39. APAC iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 40. China iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Japan iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. South Korea iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Southeast Asia iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. India iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Australia iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 46. Europe iPSC-Derived Islet Cell Therapy Market Size Market Share by Country in 2025
Figure 47. Europe iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 48. Europe iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 49. Germany iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. France iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. UK iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. Italy iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Russia iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 54. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 55. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 56. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 57. Egypt iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 58. South Africa iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 59. Israel iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 60. Turkey iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 61. GCC Countries iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 62. Americas iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 63. APAC iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 64. Europe iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 65. Middle East & Africa iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 66. United States iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 67. Canada iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 68. Mexico iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 69. Brazil iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 70. China iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 71. Japan iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 72. Korea iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 73. Southeast Asia iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 74. India iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 75. Australia iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 76. Germany iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 77. France iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 78. UK iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 79. Italy iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 80. Russia iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 81. Egypt iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 82. South Africa iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 83. Israel iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 84. Turkey iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 85. Global iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 86. Global iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 87. GCC Countries iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
